US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Longeveron Inc

0.8202

+0.099113.74%

Post-market: 0.84000.0198+2.41%19:59 EDT

Volume:377.68K

Turnover:289.77K

Market Cap:25.55M

PE:-0.73

High:0.8499

Open:0.7200

Low:0.7087

Close:0.7211

52wk High:1.80

52wk Low:0.4750

Shares:31.15M

Float Shares:26.80M

Volume Ratio:0.63

T/O Rate:1.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1195

EPS(LYR):-2.6164

ROE:-135.18%

ROA:-68.00%

PB:1.59

PE(LYR):-0.31

Loading ...

Overview Company News Filings

Longeveron shifts to capital-light model, targets licensing partners for laromestrocel

Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities

THOMSON REUTERS

Longeveron Q1 EPS $(0.19) Misses $(0.16) Estimate, Sales $398.000K Beat $314.667K Estimate

Longeveron Q1 revenue rises, beats analyst estimates

BRIEF-Longeveron Q1 EPS USD -0.19

Longeveron Q1 Revenue USD 378 Thousand

THOMSON REUTERS

Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update

Longeveron Q1 net loss narrows 6% to $4.74 million; revenue rises to $398,000

Longeveron reports DMC approval for laromestrocel study to continue as designed

Longeveron Cut to Hold From Buy by Maxim Group

Longeveron downgraded to Hold from Buy at Maxim

Longeveron DMC clears Phase 2b HLHS stem cell trial to complete

Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2B Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (Hlhs)

THOMSON REUTERS

Longeveron Inc - Top-Line Results From Elpis Ii Trial Anticipated in August 2026

THOMSON REUTERS

Longeveron Inc - DMC Finds No Safety Concerns, Recommends Phase 2B Trial Continue to Completion

THOMSON REUTERS

Longeveron provides update on laromestrocel development after Type C meeting

Longeveron Updates FDA Path for ELPIS II Trial

Longeveron Says the FDA No Longer Sees Trial for Heart Syndrome Treatment as Pivotal

Longeveron targets August ELPIS II Phase 2b HLHS data readout for laromestrocel

Longeveron Inc - FDA Says New Primary Endpoint for Elpis Ii Cannot Be Agreed While Trial Ongoing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/LGVN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LGVN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGVN\",,,,,undefined,":{"symbol":"LGVN","market":"US","secType":"STK","nameCN":"Longeveron Inc","latestPrice":0.8202,"timestamp":1779480000000,"preClose":0.7211,"halted":0,"volume":377683,"hourTrading":{"tag":"盘后","latestPrice":0.84,"preClose":0.8202,"latestTime":"19:59 EDT","volume":37888,"amount":31975.057385,"timestamp":1779494347144,"change":0.0198,"changeRate":0.02414,"amplitude":0.024384},"delay":0,"changeRate":0.1374289280266261,"floatShares":26803700,"shares":31146337,"eps":-1.119466,"marketStatus":"Not Yet Opened","change":0.0991,"latestTime":"05-22 16:00:00 EDT","open":0.72,"high":0.8499,"low":0.7087,"amount":289769.0104923,"amplitude":0.195812,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.119466,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":0,"adr":0,"listingDate":1613106000000,"exchange":"NASDAQ","adjPreClose":0.7211,"preHourTrading":{"tag":"盘前","latestPrice":0.7527,"preClose":0.7211,"latestTime":"08:48 EDT","volume":3819,"amount":2810.5762464,"timestamp":1779454136456,"change":0.0316,"changeRate":0.043822,"amplitude":0.045209},"postHourTrading":{"tag":"盘后","latestPrice":0.84,"preClose":0.8202,"latestTime":"19:59 EDT","volume":37888,"amount":31975.057385,"timestamp":1779494347144,"change":0.0198,"changeRate":0.02414,"amplitude":0.024384},"volumeRatio":0.6282470037673606},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LGVN\",,,,,undefined,":{"symbol":"LGVN","floatShares":26803700,"roa":"-68.00%","roe":"-135.18%","lyrEps":-2.61636,"volumeRatio":0.6282470037673606,"shares":31146337,"dividePrice":0,"high":0.8499,"amplitude":0.195812,"preClose":0.7211,"low":0.7087,"week52Low":0.475,"pbRate":"1.59","psRate":"21.01","week52High":1.8,"institutionHeld":0,"latestPrice":0.8202,"eps":-1.119466,"divideRate":0,"volume":377683,"delay":0,"ttmEps":-1.119466,"open":0.72,"prevYearClose":0.506,"prevWeekClose":0.8202,"prevMonthClose":0.8504,"prevQuarterClose":1.04,"fiveDayClose":0.6705,"twentyDayClose":0.94,"sixtyDayClose":0.58},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LGVN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-28","symbol":"LGVN","fiscalQuarterEnding":"2024/12","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740718800000,"reportTimeType":"post","actualEps":-2.5},{"market":"US","date":"2024-11-12","symbol":"LGVN","fiscalQuarterEnding":"2024/09","expectedEps":-0.53,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-05-14","symbol":"LGVN","fiscalQuarterEnding":"2024/03","expectedEps":-2.01,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-1.61},{"market":"US","date":"2024-03-27","symbol":"LGVN","defaultRemindTime":1711546200000,"type":"split","dateTimestamp":1711512000000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2023-08-18","symbol":"LGVN","defaultRemindTime":1692365400000,"type":"split","dateTimestamp":1692331200000,"forFactor":1040792,"toFactor":1000000,"ratio":1.040792}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LGVN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LGVN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1778731200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LGVN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LGVN","date":"2026-05-22","current":-0.732671,"percent":0.800975,"low":-56.433341,"twenty":-7.111065,"median":-2.309887,"eighty":-0.941784,"high":-0.238289,"avg":-4.608036,"sd":5.8272,"marketCap":21114628},"quantilePoints":[{"date":"2021-05-28","current":-18.929084,"twenty":-48.502169,"median":-34.617632,"eighty":-28.071104,"marketCap":125291608},{"date":"2021-06-04","current":-19.33061,"twenty":-48.486474,"median":-33.878919,"eighty":-26.899352,"marketCap":127949308},{"date":"2021-06-11","current":-20.248384,"twenty":-48.055156,"median":-33.318516,"eighty":-19.405179,"marketCap":134024053},{"date":"2021-06-18","current":-20.64991,"twenty":-47.495161,"median":-32.758112,"eighty":-19.405179,"marketCap":136681754},{"date":"2021-06-25","current":-22.514138,"twenty":-46.432919,"median":-31.484469,"eighty":-19.62315,"marketCap":149021079},{"date":"2021-07-02","current":-23.804757,"twenty":-46.14296,"median":-31.22974,"eighty":-19.881274,"marketCap":157563689},{"date":"2021-07-09","current":-21.424282,"twenty":-45.738372,"median":-31.076903,"eighty":-20.12219,"marketCap":141807320},{"date":"2021-07-16","current":-18.01131,"twenty":-45.473443,"median":-30.210826,"eighty":-19.571525,"marketCap":119216863},{"date":"2021-07-23","current":-17.753186,"twenty":-45.431244,"median":-29.675895,"eighty":-19.238833,"marketCap":117508341},{"date":"2021-07-30","current":-16.462567,"twenty":-45.246725,"median":-28.47867,"eighty":-18.946292,"marketCap":108965731},{"date":"2021-08-06","current":-16.921454,"twenty":-45.062206,"median":-27.485228,"eighty":-18.625072,"marketCap":112003104},{"date":"2021-08-13","current":-7.15835,"twenty":-44.890866,"median":-26.491786,"eighty":-17.999838,"marketCap":74547057},{"date":"2021-08-20","current":-6.552643,"twenty":-43.348813,"median":-23.532293,"eighty":-17.667145,"marketCap":68239229},{"date":"2021-08-27","current":-6.479224,"twenty":-41.631425,"median":-22.973025,"eighty":-17.414758,"marketCap":67474643},{"date":"2021-09-03","current":-6.864674,"twenty":-41.056573,"median":-22.169973,"eighty":-16.909982,"marketCap":71488716},{"date":"2021-09-10","current":-6.846319,"twenty":-40.839572,"median":-21.625045,"eighty":-16.577289,"marketCap":71297569},{"date":"2021-09-17","current":-6.644417,"twenty":-40.063267,"median":-21.280879,"eighty":-16.330637,"marketCap":69194960},{"date":"2021-09-24","current":-6.791255,"twenty":-38.82346,"median":-20.965394,"eighty":-15.326822,"marketCap":70724131},{"date":"2021-10-01","current":-6.699481,"twenty":-38.014093,"median":-20.64991,"eighty":-7.048222,"marketCap":69768399},{"date":"2021-10-08","current":-6.277322,"twenty":-37.595528,"median":-20.305745,"eighty":-6.864674,"marketCap":65372034},{"date":"2021-10-15","current":-7.305188,"twenty":-36.925474,"median":-19.674775,"eighty":-6.853661,"marketCap":76076227},{"date":"2021-10-22","current":-6.185549,"twenty":-35.926938,"median":-19.34495,"eighty":-6.813281,"marketCap":64416303},{"date":"2021-10-29","current":-6.332386,"twenty":-35.030293,"median":-19.101167,"eighty":-6.706823,"marketCap":65945473},{"date":"2021-11-05","current":-7.15835,"twenty":-34.632916,"median":-18.979275,"eighty":-6.706823,"marketCap":74547057},{"date":"2021-11-12","current":-4.536013,"twenty":-34.378188,"median":-18.929084,"eighty":-6.677456,"marketCap":65010142},{"date":"2021-11-19","current":-13.381239,"twenty":-33.929865,"median":-18.584919,"eighty":-6.651759,"marketCap":191779918},{"date":"2021-11-26","current":-40.917508,"twenty":-34.663484,"median":-18.871723,"eighty":-6.662772,"marketCap":586429722},{"date":"2021-12-03","current":-28.484032,"twenty":-34.955363,"median":-18.957764,"eighty":-6.670114,"marketCap":408233150},{"date":"2021-12-10","current":-27.507194,"twenty":-34.663484,"median":-19.086827,"eighty":-6.699481,"marketCap":394233106},{"date":"2021-12-17","current":-24.619151,"twenty":-34.459701,"median":-19.33061,"eighty":-6.699481,"marketCap":352841674},{"date":"2021-12-23","current":-19.395191,"twenty":-34.133648,"median":-19.395191,"eighty":-6.699481,"marketCap":277971876},{"date":"2021-12-31","current":-17.087588,"twenty":-33.62419,"median":-19.33061,"eighty":-6.717836,"marketCap":244899310},{"date":"2022-01-07","current":-13.718204,"twenty":-33.573245,"median":-19.072486,"eighty":-6.754546,"marketCap":196609305},{"date":"2022-01-14","current":-12.854623,"twenty":-33.318516,"median":-18.943424,"eighty":-6.791255,"marketCap":184232455},{"date":"2022-01-21","current":-9.315354,"twenty":-33.237002,"median":-18.871723,"eighty":-6.791255,"marketCap":133507660},{"date":"2022-01-28","current":-9.980737,"twenty":-33.094354,"median":-18.384156,"eighty":-6.820623,"marketCap":143043921},{"date":"2022-02-04","current":-10.561177,"twenty":-32.574708,"median":-18.169052,"eighty":-6.842648,"marketCap":151362788},{"date":"2022-02-11","current":-9.86748,"twenty":-31.881846,"median":-17.937012,"eighty":-6.861003,"marketCap":141420728},{"date":"2022-02-18","current":-9.088841,"twenty":-31.535415,"median":-17.710166,"eighty":-6.864674,"marketCap":130261273},{"date":"2022-02-25","current":-8.749072,"twenty":-31.453901,"median":-17.660508,"eighty":-6.8867,"marketCap":125391693},{"date":"2022-03-04","current":-8.720757,"twenty":-31.372388,"median":-17.581104,"eighty":-6.901384,"marketCap":124985894},{"date":"2022-03-11","current":-8.219862,"twenty":-31.209362,"median":-17.333064,"eighty":-6.934422,"marketCap":140107545},{"date":"2022-03-18","current":-8.416157,"twenty":-31.097281,"median":-17.087588,"eighty":-6.956448,"marketCap":143453397},{"date":"2022-03-25","current":-8.268936,"twenty":-31.076903,"median":-16.921454,"eighty":-6.967461,"marketCap":140944008},{"date":"2022-04-01","current":-19.151051,"twenty":-31.033156,"median":-16.921454,"eighty":-6.985815,"marketCap":326429670},{"date":"2022-04-08","current":-11.728639,"twenty":-30.803199,"median":-16.83276,"eighty":-6.993157,"marketCap":199914647},{"date":"2022-04-14","current":-12.03535,"twenty":-30.485933,"median":-16.60597,"eighty":-7.000499,"marketCap":205142540},{"date":"2022-04-22","current":-15.163805,"twenty":-30.149691,"median":-16.462567,"eighty":-7.04088,"marketCap":258467054},{"date":"2022-04-29","current":-12.292987,"twenty":-30.03761,"median":-16.347845,"eighty":-7.114299,"marketCap":209533971},{"date":"2022-05-06","current":-10.268693,"twenty":-29.742124,"median":-16.290485,"eighty":-7.15835,"marketCap":175029874},{"date":"2022-05-13","current":-9.602157,"twenty":-29.283613,"median":-15.640536,"eighty":-7.15835,"marketCap":167500032},{"date":"2022-05-20","current":-9.830208,"twenty":-28.982376,"median":-15.171948,"eighty":-7.160402,"marketCap":171478157},{"date":"2022-05-27","current":-9.662171,"twenty":-28.594457,"median":-14.735002,"eighty":-7.213071,"marketCap":168546907},{"date":"2022-06-03","current":-10.478354,"twenty":-28.48296,"median":-14.280476,"eighty":-7.291006,"marketCap":182784409},{"date":"2022-06-10","current":-8.605933,"twenty":-28.397157,"median":-13.986034,"eighty":-7.348262,"marketCap":150121903},{"date":"2022-06-17","current":-7.225623,"twenty":-28.000793,"median":-13.490192,"eighty":-7.348262,"marketCap":126043774},{"date":"2022-06-24","current":-8.149831,"twenty":-27.71955,"median":-13.34012,"eighty":-7.28746,"marketCap":142165652},{"date":"2022-07-01","current":-7.129602,"twenty":-27.714484,"median":-12.897094,"eighty":-7.237626,"marketCap":124368773},{"date":"2022-07-08","current":-8.689952,"twenty":-27.548652,"median":-12.771457,"eighty":-7.277493,"marketCap":151587528},{"date":"2022-07-15","current":-7.585704,"twenty":-27.306321,"median":-12.480832,"eighty":-7.295604,"marketCap":132325025},{"date":"2022-07-22","current":-7.393661,"twenty":-27.255998,"median":-12.243914,"eighty":-7.303678,"marketCap":128975024},{"date":"2022-07-29","current":-7.47768,"twenty":-27.05219,"median":-11.992411,"eighty":-7.295604,"marketCap":130440649},{"date":"2022-08-05","current":-7.261631,"twenty":-26.986954,"median":-11.728639,"eighty":-7.295604,"marketCap":126671899},{"date":"2022-08-12","current":-6.915094,"twenty":-26.590105,"median":-11.385117,"eighty":-7.261631,"marketCap":124872769},{"date":"2022-08-19","current":-6.13642,"twenty":-25.956359,"median":-10.955726,"eighty":-7.223223,"marketCap":110811465},{"date":"2022-08-26","current":-6.043444,"twenty":-25.233568,"median":-10.809898,"eighty":-7.162453,"marketCap":109132504},{"date":"2022-09-02","current":-5.334501,"twenty":-25.01838,"median":-10.575334,"eighty":-7.129602,"marketCap":96330421},{"date":"2022-09-09","current":-5.903979,"twenty":-24.772047,"median":-10.504549,"eighty":-7.055563,"marketCap":106614061},{"date":"2022-09-16","current":-5.299635,"twenty":-24.568186,"median":-10.355899,"eighty":-6.985815,"marketCap":95700811},{"date":"2022-09-23","current":-4.695291,"twenty":-24.222196,"median":-10.150622,"eighty":-6.90961,"marketCap":84787560},{"date":"2022-09-30","current":-4.300143,"twenty":-23.952453,"median":-10.086915,"eighty":-6.861598,"marketCap":77651974},{"date":"2022-10-07","current":-4.067702,"twenty":-23.847373,"median":-10.023208,"eighty":-6.791255,"marketCap":73454570},{"date":"2022-10-14","current":-4.021214,"twenty":-23.77034,"median":-9.994894,"eighty":-6.699481,"marketCap":72615089},{"date":"2022-10-21","current":-4.207166,"twenty":-23.489272,"median":-9.909952,"eighty":-6.65543,"marketCap":75973012},{"date":"2022-10-28","current":-4.195544,"twenty":-23.145108,"median":-9.827609,"eighty":-6.570998,"marketCap":75763142},{"date":"2022-11-04","current":-3.835262,"twenty":-22.996298,"median":-9.806203,"eighty":-6.534289,"marketCap":69257166},{"date":"2022-11-11","current":-4.544205,"twenty":-22.973244,"median":-9.732066,"eighty":-6.479224,"marketCap":82059248},{"date":"2022-11-18","current":-4.568971,"twenty":-22.886984,"median":-9.640967,"eighty":-6.446186,"marketCap":84283804},{"date":"2022-11-25","current":-4.888001,"twenty":-22.741313,"median":-9.602157,"eighty":-6.405805,"marketCap":90168957},{"date":"2022-12-02","current":-4.284122,"twenty":-22.570963,"median":-9.514769,"eighty":-6.387451,"marketCap":79029202},{"date":"2022-12-09","current":-3.714425,"twenty":-22.444428,"median":-9.458125,"eighty":-6.332386,"marketCap":68520000},{"date":"2022-12-16","current":-3.543516,"twenty":-22.13424,"median":-9.422117,"eighty":-6.284664,"marketCap":65367239},{"date":"2022-12-23","current":-3.725819,"twenty":-21.802864,"median":-9.371983,"eighty":-6.176991,"marketCap":68730184},{"date":"2022-12-30","current":-3.668849,"twenty":-21.711086,"median":-9.315354,"eighty":-6.138904,"marketCap":67679264},{"date":"2023-01-06","current":-4.067637,"twenty":-21.481642,"median":-9.182063,"eighty":-6.043444,"marketCap":75035705},{"date":"2023-01-13","current":-4.215759,"twenty":-21.424282,"median":-9.117155,"eighty":-5.915601,"marketCap":77768098},{"date":"2023-01-20","current":-4.500607,"twenty":-21.30956,"median":-9.000806,"eighty":-5.678512,"marketCap":83022699},{"date":"2023-01-27","current":-4.73988,"twenty":-21.234991,"median":-8.893998,"eighty":-5.548346,"marketCap":87436564},{"date":"2023-02-03","current":-4.603153,"twenty":-21.085853,"median":-8.803446,"eighty":-5.274067,"marketCap":84914356},{"date":"2023-02-10","current":-4.113213,"twenty":-20.91377,"median":-8.720757,"eighty":-4.912766,"marketCap":75876442},{"date":"2023-02-17","current":-4.033455,"twenty":-20.741687,"median":-8.605933,"eighty":-4.827782,"marketCap":74405153},{"date":"2023-02-24","current":-3.93091,"twenty":-20.672854,"median":-8.569513,"eighty":-4.694896,"marketCap":72513497},{"date":"2023-03-03","current":-4.090425,"twenty":-20.598285,"median":-8.416157,"eighty":-4.68291,"marketCap":75456073},{"date":"2023-03-10","current":-3.437042,"twenty":-20.443411,"median":-8.263395,"eighty":-4.603153,"marketCap":64736687},{"date":"2023-03-17","current":-3.126922,"twenty":-20.294273,"median":-8.219862,"eighty":-4.553749,"marketCap":58895578},{"date":"2023-03-24","current":-3.093419,"twenty":-20.059093,"median":-8.166443,"eighty":-4.540928,"marketCap":58264553},{"date":"2023-03-31","current":-2.981744,"twenty":-19.778025,"median":-7.99903,"eighty":-4.512001,"marketCap":56161140},{"date":"2023-04-06","current":-2.8589,"twenty":-19.571525,"median":-7.957788,"eighty":-4.498873,"marketCap":53847385},{"date":"2023-04-14","current":-3.13809,"twenty":-19.408067,"median":-7.93795,"eighty":-4.455031,"marketCap":59105919},{"date":"2023-04-21","current":-3.171592,"twenty":-19.380831,"median":-7.819121,"eighty":-4.404835,"marketCap":59736943},{"date":"2023-04-28","current":-3.13809,"twenty":-19.347819,"median":-7.681726,"eighty":-4.316523,"marketCap":59105919},{"date":"2023-05-05","current":-3.319422,"twenty":-19.33061,"median":-7.645718,"eighty":-4.210603,"marketCap":62521321},{"date":"2023-05-12","current":-3.855895,"twenty":-19.258786,"median":-7.5677,"eighty":-4.188571,"marketCap":72625777},{"date":"2023-05-19","current":-3.341253,"twenty":-19.131097,"median":-7.525445,"eighty":-4.170183,"marketCap":66731511},{"date":"2023-05-26","current":-3.272255,"twenty":-19.089695,"median":-7.447673,"eighty":-4.134387,"marketCap":65353468},{"date":"2023-06-02","current":-3.335589,"twenty":-19.058146,"median":-7.387659,"eighty":-4.092704,"marketCap":66618374},{"date":"2023-06-09","current":-3.683925,"twenty":-18.992181,"median":-7.321645,"eighty":-4.079031,"marketCap":73575356},{"date":"2023-06-16","current":-3.736704,"twenty":-18.952028,"median":-7.321645,"eighty":-4.058522,"marketCap":74629444},{"date":"2023-06-23","current":-3.905594,"twenty":-18.929084,"median":-7.309642,"eighty":-4.044458,"marketCap":78002526},{"date":"2023-06-30","current":-3.588662,"twenty":-18.929084,"median":-7.301414,"eighty":-4.030512,"marketCap":71672749},{"date":"2023-07-07","current":-3.175807,"twenty":-18.860251,"median":-7.29255,"eighty":-4.013656,"marketCap":63427212},{"date":"2023-07-14","current":-3.546317,"twenty":-18.797154,"median":-7.261631,"eighty":-3.988563,"marketCap":70827053},{"date":"2023-07-21","current":-3.662764,"twenty":-18.544766,"median":-7.231624,"eighty":-3.974726,"marketCap":73152717},{"date":"2023-07-28","current":-3.546317,"twenty":-18.384156,"median":-7.201618,"eighty":-3.956502,"marketCap":70827053},{"date":"2023-08-04","current":-3.592881,"twenty":-18.349739,"median":-7.160915,"eighty":-3.93091,"marketCap":71757024},{"date":"2023-08-11","current":-3.444503,"twenty":-18.137504,"median":-7.15835,"eighty":-3.920784,"marketCap":68793608},{"date":"2023-08-18","current":-2.948161,"twenty":-17.994102,"median":-7.123601,"eighty":-3.863042,"marketCap":58904262},{"date":"2023-08-25","current":-2.669745,"twenty":-17.955259,"median":-7.011512,"eighty":-3.835262,"marketCap":53341505},{"date":"2023-09-01","current":-2.976978,"twenty":-17.89555,"median":-6.993157,"eighty":-3.822281,"marketCap":59480011},{"date":"2023-09-08","current":-2.542614,"twenty":-17.822019,"median":-6.965625,"eighty":-3.811521,"marketCap":50801433},{"date":"2023-09-15","current":-2.468455,"twenty":-17.71877,"median":-6.915094,"eighty":-3.771793,"marketCap":49319725},{"date":"2023-09-22","current":-2.426078,"twenty":-17.667145,"median":-6.883029,"eighty":-3.718983,"marketCap":48473034},{"date":"2023-09-29","current":-2.415484,"twenty":-17.661835,"median":-6.856984,"eighty":-3.690753,"marketCap":48261361},{"date":"2023-10-06","current":-2.214193,"twenty":-17.636236,"median":-6.80961,"eighty":-3.659579,"marketCap":44239581},{"date":"2023-10-13","current":-1.980251,"twenty":-17.598312,"median":-6.754546,"eighty":-3.624757,"marketCap":39565422},{"date":"2023-10-20","current":-2.288554,"twenty":-17.523743,"median":-6.699481,"eighty":-3.58231,"marketCap":45725309},{"date":"2023-10-27","current":-2.252981,"twenty":-17.466382,"median":-6.699481,"eighty":-3.56025,"marketCap":45014553},{"date":"2023-11-03","current":-2.41899,"twenty":-17.391813,"median":-6.662772,"eighty":-3.546317,"marketCap":48331414},{"date":"2023-11-10","current":-2.288554,"twenty":-17.304698,"median":-6.589353,"eighty":-3.531279,"marketCap":45725309},{"date":"2023-11-17","current":-2.178562,"twenty":-17.149879,"median":-6.570998,"eighty":-3.505973,"marketCap":43227025},{"date":"2023-11-24","current":-2.334173,"twenty":-17.098914,"median":-6.552643,"eighty":-3.478451,"marketCap":46314670},{"date":"2023-12-01","current":-2.346144,"twenty":-17.022324,"median":-6.515934,"eighty":-3.46349,"marketCap":46552181},{"date":"2023-12-08","current":-2.836919,"twenty":-16.949803,"median":-6.479224,"eighty":-3.442885,"marketCap":56290137},{"date":"2023-12-15","current":-2.477815,"twenty":-16.925057,"median":-6.467164,"eighty":-3.432578,"marketCap":49164803},{"date":"2023-12-22","current":-1.496265,"twenty":-16.921454,"median":-6.42416,"eighty":-3.407935,"marketCap":29688891},{"date":"2023-12-29","current":-1.663847,"twenty":-16.915718,"median":-6.405805,"eighty":-3.364573,"marketCap":33014047},{"date":"2024-01-05","current":-1.695584,"twenty":-16.89851,"median":-6.405805,"eighty":-3.34012,"marketCap":33643786},{"date":"2024-01-12","current":-1.480473,"twenty":-16.87874,"median":-6.387451,"eighty":-3.281496,"marketCap":29375544},{"date":"2024-01-19","current":-1.290669,"twenty":-16.824266,"median":-6.369096,"eighty":-3.249023,"marketCap":25609449},{"date":"2024-01-26","current":-1.0338,"twenty":-16.696906,"median":-6.332386,"eighty":-3.205095,"marketCap":20512666},{"date":"2024-02-02","current":-0.646816,"twenty":-16.600233,"median":-6.314032,"eighty":-3.203217,"marketCap":12834128},{"date":"2024-02-09","current":-0.653022,"twenty":-16.577289,"median":-6.277322,"eighty":-3.193928,"marketCap":12957267},{"date":"2024-02-16","current":-0.672527,"twenty":-16.508456,"median":-6.194726,"eighty":-3.174121,"marketCap":13344276},{"date":"2024-02-23","current":-0.649223,"twenty":-16.446422,"median":-6.165475,"eighty":-3.13809,"marketCap":12881876},{"date":"2024-03-01","current":-0.626707,"twenty":-16.392461,"median":-6.13642,"eighty":-3.119242,"marketCap":13419668},{"date":"2024-03-08","current":-0.604507,"twenty":-16.347845,"median":-6.043444,"eighty":-3.086719,"marketCap":12944316},{"date":"2024-03-15","current":-0.539948,"twenty":-16.336373,"median":-6.031822,"eighty":-3.037469,"marketCap":11561914},{"date":"2024-03-22","current":-0.457797,"twenty":-16.307693,"median":-5.90979,"eighty":-3.001845,"marketCap":9802813},{"date":"2024-03-28","current":-0.365064,"twenty":-16.250332,"median":-5.706405,"eighty":-2.983977,"marketCap":7817112},{"date":"2024-04-05","current":-0.238289,"twenty":-16.024769,"median":-5.625051,"eighty":-2.958746,"marketCap":5102488},{"date":"2024-04-12","current":-0.306251,"twenty":-15.71519,"median":-5.52917,"eighty":-2.918711,"marketCap":6557744},{"date":"2024-04-19","current":-0.450382,"twenty":-15.453016,"median":-5.334501,"eighty":-2.841315,"marketCap":9644030},{"date":"2024-04-26","current":-0.561354,"twenty":-15.194892,"median":-5.069776,"eighty":-2.724673,"marketCap":12020274},{"date":"2024-05-03","current":-0.608414,"twenty":-15.170319,"median":-4.916109,"eighty":-2.66127,"marketCap":13027961},{"date":"2024-05-10","current":-0.517656,"twenty":-15.15399,"median":-4.882304,"eighty":-2.574397,"marketCap":11084564},{"date":"2024-05-17","current":-0.445886,"twenty":-14.962839,"median":-4.799889,"eighty":-2.544018,"marketCap":9285122},{"date":"2024-05-24","current":-0.341455,"twenty":-14.350128,"median":-4.694797,"eighty":-2.481196,"marketCap":7110458},{"date":"2024-05-31","current":-0.332309,"twenty":-14.32955,"median":-4.683289,"eighty":-2.468455,"marketCap":6920000},{"date":"2024-06-07","current":-0.320114,"twenty":-14.231403,"median":-4.68291,"eighty":-2.442705,"marketCap":6666055},{"date":"2024-06-14","current":-0.820102,"twenty":-14.17194,"median":-4.613937,"eighty":-2.429163,"marketCap":17077798},{"date":"2024-06-21","current":-0.746933,"twenty":-14.05445,"median":-4.603153,"eighty":-2.417588,"marketCap":15554128},{"date":"2024-06-28","current":-0.512182,"twenty":-13.986034,"median":-4.591759,"eighty":-2.404889,"marketCap":10665688},{"date":"2024-07-05","current":-0.503036,"twenty":-13.77177,"median":-4.557577,"eighty":-2.344112,"marketCap":10475229},{"date":"2024-07-12","current":-1.185946,"twenty":-13.57097,"median":-4.546183,"eighty":-2.334173,"marketCap":24696147},{"date":"2024-07-15","current":-2.024011,"twenty":-13.534162,"median":-4.546183,"eighty":-2.334173,"marketCap":42148012},{"date":"2024-08-02","current":-2.096274,"twenty":-13.516574,"median":-4.545194,"eighty":-2.334173,"marketCap":43652813},{"date":"2024-08-09","current":-1.758388,"twenty":-13.433225,"median":-4.520961,"eighty":-2.31064,"marketCap":36616668},{"date":"2024-08-16","current":-1.898646,"twenty":-13.364791,"median":-4.512001,"eighty":-2.29924,"marketCap":35324315},{"date":"2024-08-23","current":-2.029854,"twenty":-13.222936,"median":-4.500607,"eighty":-2.288554,"marketCap":37765427},{"date":"2024-08-30","current":-1.613078,"twenty":-12.914361,"median":-4.480896,"eighty":-2.277759,"marketCap":30011309},{"date":"2024-09-06","current":-1.667104,"twenty":-12.897094,"median":-4.462817,"eighty":-2.252981,"marketCap":31016472},{"date":"2024-09-13","current":-1.559051,"twenty":-12.854623,"median":-4.427985,"eighty":-2.217407,"marketCap":29006145},{"date":"2024-09-20","current":-1.589923,"twenty":-12.771457,"median":-4.406757,"eighty":-2.173128,"marketCap":29580524},{"date":"2024-09-27","current":-1.520461,"twenty":-12.501551,"median":-4.358253,"eighty":-2.075114,"marketCap":28288171},{"date":"2024-10-04","current":-1.381535,"twenty":-12.489283,"median":-4.29783,"eighty":-1.99284,"marketCap":25703465},{"date":"2024-10-11","current":-1.373817,"twenty":-12.472382,"median":-4.222264,"eighty":-1.970526,"marketCap":25559870},{"date":"2024-10-18","current":-1.705694,"twenty":-12.292987,"median":-4.207166,"eighty":-1.860056,"marketCap":31734446},{"date":"2024-10-25","current":-1.597641,"twenty":-12.243914,"median":-4.183922,"eighty":-1.813748,"marketCap":29724119},{"date":"2024-10-31","current":-1.667104,"twenty":-12.077063,"median":-4.181577,"eighty":-1.759454,"marketCap":31016472},{"date":"2024-11-08","current":-1.697976,"twenty":-12.005906,"median":-4.169657,"eighty":-1.745424,"marketCap":31590851},{"date":"2024-11-15","current":-1.666725,"twenty":-11.98873,"median":-4.149056,"eighty":-1.721811,"marketCap":29867714},{"date":"2024-11-22","current":-1.49845,"twenty":-11.899483,"median":-4.107516,"eighty":-1.702334,"marketCap":26852223},{"date":"2024-11-29","current":-1.697287,"twenty":-11.788297,"median":-4.084874,"eighty":-1.6977,"marketCap":30415388},{"date":"2024-12-06","current":-1.556537,"twenty":-11.581418,"median":-4.079031,"eighty":-1.693454,"marketCap":27893137},{"date":"2024-12-13","current":-1.539978,"twenty":-11.468548,"median":-4.06767,"eighty":-1.687171,"marketCap":27596401},{"date":"2024-12-20","current":-1.324712,"twenty":-11.370394,"median":-4.056243,"eighty":-1.669008,"marketCap":23738840},{"date":"2024-12-27","current":-1.523419,"twenty":-11.306598,"median":-4.044458,"eighty":-1.666877,"marketCap":27299666},{"date":"2025-01-03","current":-1.482022,"twenty":-11.23054,"median":-4.033455,"eighty":-1.660278,"marketCap":26557827},{"date":"2025-01-10","current":-1.49858,"twenty":-10.955726,"median":-4.021214,"eighty":-1.647611,"marketCap":26854562},{"date":"2025-01-17","current":-1.457183,"twenty":-10.946459,"median":-4.012979,"eighty":-1.632316,"marketCap":26112724},{"date":"2025-01-24","current":-1.407507,"twenty":-10.887398,"median":-3.998622,"eighty":-1.62215,"marketCap":25222517},{"date":"2025-01-31","current":-1.324712,"twenty":-10.772257,"median":-3.986348,"eighty":-1.60536,"marketCap":23738840},{"date":"2025-02-07","current":-1.332991,"twenty":-10.700305,"median":-3.974726,"eighty":-1.596984,"marketCap":23887207},{"date":"2025-02-14","current":-1.299874,"twenty":-10.597985,"median":-3.965092,"eighty":-1.589257,"marketCap":23293736},{"date":"2025-02-21","current":-1.35783,"twenty":-10.56684,"median":-3.958372,"eighty":-1.581873,"marketCap":24332311},{"date":"2025-02-28","current":-1.266756,"twenty":-10.5272,"median":-3.94548,"eighty":-1.573931,"marketCap":22700265},{"date":"2025-03-07","current":-1.337567,"twenty":-10.488832,"median":-3.93091,"eighty":-1.558045,"marketCap":21364956},{"date":"2025-03-14","current":-1.532696,"twenty":-10.409128,"median":-3.93091,"eighty":-1.545363,"marketCap":24481760},{"date":"2025-03-21","current":-1.644845,"twenty":-10.354484,"median":-3.896728,"eighty":-1.545363,"marketCap":26273109},{"date":"2025-03-28","current":-1.588771,"twenty":-10.300744,"median":-3.862959,"eighty":-1.549411,"marketCap":25377435},{"date":"2025-04-04","current":-1.355128,"twenty":-10.19785,"median":-3.839758,"eighty":-1.541216,"marketCap":21645459},{"date":"2025-04-11","current":-1.261671,"twenty":-10.150622,"median":-3.831813,"eighty":-1.530889,"marketCap":20152669},{"date":"2025-04-17","current":-1.317745,"twenty":-10.127971,"median":-3.8257,"eighty":-1.520461,"marketCap":21048343},{"date":"2025-04-25","current":-1.523351,"twenty":-10.088331,"median":-3.816971,"eighty":-1.504805,"marketCap":24332481},{"date":"2025-05-02","current":-1.457931,"twenty":-10.076006,"median":-3.808383,"eighty":-1.501012,"marketCap":23287528},{"date":"2025-05-09","current":-1.392511,"twenty":-10.05144,"median":-3.789482,"eighty":-1.497306,"marketCap":22242575},{"date":"2025-05-16","current":-1.234731,"twenty":-10.017545,"median":-3.736785,"eighty":-1.48758,"marketCap":20899064},{"date":"2025-05-23","current":-1.212683,"twenty":-10.009051,"median":-3.714425,"eighty":-1.481093,"marketCap":20525866},{"date":"2025-05-30","current":-1.155356,"twenty":-10.003388,"median":-3.705037,"eighty":-1.467119,"marketCap":19555552},{"date":"2025-06-06","current":-1.046377,"twenty":-9.980737,"median":-3.686096,"eighty":-1.457931,"marketCap":17710981},{"date":"2025-06-13","current":-1.170524,"twenty":-9.96658,"median":-3.662764,"eighty":-1.457183,"marketCap":19812283},{"date":"2025-06-20","current":-1.07298,"twenty":-9.909952,"median":-3.652178,"eighty":-1.450998,"marketCap":18161260},{"date":"2025-06-27","current":-1.152788,"twenty":-9.86748,"median":-3.625799,"eighty":-1.448585,"marketCap":19512097},{"date":"2025-07-03","current":-1.161656,"twenty":-9.837662,"median":-3.601459,"eighty":-1.423362,"marketCap":19662190},{"date":"2025-07-11","current":-1.330141,"twenty":-9.826049,"median":-3.578076,"eighty":-1.418476,"marketCap":22513959},{"date":"2025-07-18","current":-1.365611,"twenty":-9.825009,"median":-3.554442,"eighty":-1.406944,"marketCap":23114331},{"date":"2025-07-25","current":-1.498625,"twenty":-9.809964,"median":-3.546317,"eighty":-1.406944,"marketCap":25365727},{"date":"2025-08-01","current":-1.436552,"twenty":-9.796601,"median":-3.544917,"eighty":-1.404123,"marketCap":24315075},{"date":"2025-08-08","current":-1.126186,"twenty":-9.781204,"median":-3.52929,"eighty":-1.401702,"marketCap":19061818},{"date":"2025-08-15","current":-0.847058,"twenty":-9.704532,"median":-3.508713,"eighty":-1.392511,"marketCap":15705307},{"date":"2025-08-22","current":-0.654919,"twenty":-9.666972,"median":-3.483368,"eighty":-1.38321,"marketCap":12142860},{"date":"2025-08-29","current":-0.942693,"twenty":-9.645208,"median":-3.477287,"eighty":-1.374461,"marketCap":17478464},{"date":"2025-09-05","current":-0.849775,"twenty":-9.627466,"median":-3.468263,"eighty":-1.370734,"marketCap":15755680},{"date":"2025-09-12","current":-0.903049,"twenty":-9.60868,"median":-3.45354,"eighty":-1.364474,"marketCap":16743438},{"date":"2025-09-19","current":-0.874652,"twenty":-9.582972,"median":-3.44248,"eighty":-1.353259,"marketCap":16216915},{"date":"2025-09-26","current":-0.901459,"twenty":-9.546157,"median":-3.437042,"eighty":-1.331851,"marketCap":16713953},{"date":"2025-10-03","current":-0.869199,"twenty":-9.511694,"median":-3.424386,"eighty":-1.324712,"marketCap":16115822},{"date":"2025-10-10","current":-1.005168,"twenty":-9.490902,"median":-3.408699,"eighty":-1.31625,"marketCap":18636816},{"date":"2025-10-17","current":-0.939966,"twenty":-9.468971,"median":-3.365241,"eighty":-1.303452,"marketCap":17427918},{"date":"2025-10-24","current":-0.965524,"twenty":-9.443722,"median":-3.341253,"eighty":-1.298512,"marketCap":17901789},{"date":"2025-10-31","current":-0.951098,"twenty":-9.426918,"median":-3.327009,"eighty":-1.287727,"marketCap":17634315},{"date":"2025-11-07","current":-0.759895,"twenty":-9.422117,"median":-3.280813,"eighty":-1.275035,"marketCap":16216915},{"date":"2025-11-14","current":-0.689538,"twenty":-9.417519,"median":-3.245855,"eighty":-1.261671,"marketCap":14715421},{"date":"2025-11-21","current":-0.60317,"twenty":-9.388971,"median":-3.220645,"eighty":-1.256034,"marketCap":12872260},{"date":"2025-11-28","current":-0.663447,"twenty":-9.357706,"median":-3.205095,"eighty":-1.24523,"marketCap":14158633},{"date":"2025-12-05","current":-0.632459,"twenty":-9.327916,"median":-3.204662,"eighty":-1.229108,"marketCap":13497313},{"date":"2025-12-12","current":-0.626761,"twenty":-9.270052,"median":-3.196481,"eighty":-1.214441,"marketCap":13375716},{"date":"2025-12-19","current":-0.55099,"twenty":-9.194084,"median":-3.193928,"eighty":-1.195218,"marketCap":11758684},{"date":"2025-12-26","current":-0.532197,"twenty":-9.178733,"median":-3.180007,"eighty":-1.18264,"marketCap":11357625},{"date":"2026-01-02","current":-0.505807,"twenty":-9.165415,"median":-3.173699,"eighty":-1.177559,"marketCap":10794437},{"date":"2026-01-09","current":-0.628761,"twenty":-9.14547,"median":-3.13809,"eighty":-1.161656,"marketCap":13418382},{"date":"2026-01-16","current":-0.563785,"twenty":-9.088841,"median":-3.126922,"eighty":-1.152788,"marketCap":12031744},{"date":"2026-01-23","current":-0.548491,"twenty":-9.038591,"median":-3.120114,"eighty":-1.142147,"marketCap":11705351},{"date":"2026-01-30","current":-0.579579,"twenty":-8.985674,"median":-3.104108,"eighty":-1.125846,"marketCap":12368804},{"date":"2026-02-06","current":-0.510806,"twenty":-8.919918,"median":-3.082252,"eighty":-1.09839,"marketCap":10901102},{"date":"2026-02-13","current":-0.533997,"twenty":-8.836071,"median":-3.028181,"eighty":-1.074754,"marketCap":11396025},{"date":"2026-02-20","current":-0.559787,"twenty":-8.673148,"median":-2.992911,"eighty":-1.053603,"marketCap":11946413},{"date":"2026-02-27","current":-0.579779,"twenty":-8.50449,"median":-2.973777,"eighty":-1.038217,"marketCap":12373070},{"date":"2026-03-06","current":-0.495711,"twenty":-8.239492,"median":-2.924669,"eighty":-1.005895,"marketCap":10578975},{"date":"2026-03-13","current":-0.808692,"twenty":-8.100467,"median":-2.825575,"eighty":-0.955324,"marketCap":17258300},{"date":"2026-03-20","current":-1.431557,"twenty":-7.940451,"median":-2.712122,"eighty":-0.955324,"marketCap":32502063},{"date":"2026-03-27","current":-1.25474,"twenty":-7.703331,"median":-2.579694,"eighty":-0.955324,"marketCap":28487619},{"date":"2026-04-02","current":-1.444454,"twenty":-7.633715,"median":-2.549636,"eighty":-0.955324,"marketCap":32794874},{"date":"2026-04-10","current":-1.431557,"twenty":-7.511984,"median":-2.484417,"eighty":-0.955324,"marketCap":32502063},{"date":"2026-04-17","current":-1.41866,"twenty":-7.350451,"median":-2.463158,"eighty":-0.955324,"marketCap":32209251},{"date":"2026-04-24","current":-1.259254,"twenty":-7.309642,"median":-2.433303,"eighty":-0.955324,"marketCap":28590103},{"date":"2026-05-01","current":-1.096753,"twenty":-7.282294,"median":-2.410187,"eighty":-0.955324,"marketCap":24900679},{"date":"2026-05-08","current":-1.098559,"twenty":-7.223223,"median":-2.335985,"eighty":-0.955324,"marketCap":24941673},{"date":"2026-05-15","current":-0.917247,"twenty":-7.15835,"median":-2.332451,"eighty":-0.951507,"marketCap":20572927},{"date":"2026-05-22","current":-0.941399,"twenty":-7.111065,"median":-2.309887,"eighty":-0.941784,"marketCap":21114628}],"updateTime":1779768006010},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LGVN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2637878512","title":"Longeveron shifts to capital-light model, targets licensing partners for laromestrocel","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878512","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878512?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:06","pubTimestamp":1779307612,"startTime":"0","endTime":"0","summary":"Longeveron shifted to a more capital-efficient plan centered on licensing partnerships for its stem cell therapy laromestrocel, aiming to rely on partners’ commercial scale and funding to advance development.Strategy prioritizes the Phase 2b ELPIS II readout in hypoplastic left heart syndrome, with top-line 12-month data expected in August 2026, to support FDA discussions on a potential path to a biologics license application.Planning includes advancing pediatric dilated cardiomyopathy into a single Phase 2 registrational trial in 2027, contingent on financing or a partnership.Alzheimer’s disease development is positioned for partnering and non-dilutive funding, based on an FDA-aligned single Phase 2/3 adaptive trial design that could support a future biologics license application.Capital plan targets lower cash burn and reduced dilution, supported by a March private placement for up to USD 30 million, with USD 15 million upfront and up to USD 15 million tied to ELPIS II results and sh","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL4wmq0b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4585","SG9999014021.USD","LU0314104364.USD","NDAQ","IE00BN0W2W23.USD","SG9999014005.SGD","BK4139","LU2210150020.SGD","IE00BN0W2T93.GBP","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2210149790.SGD","IE00B3QW5Z07.USD","LU2095319765.USD","BK4588","SG9999014039.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878518","title":"Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878518","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878518?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:05","pubTimestamp":1779307500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA2MLJVC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635557537","title":"Longeveron Q1 EPS $(0.19) Misses $(0.16) Estimate, Sales $398.000K Beat $314.667K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635557537","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635557537?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:42","pubTimestamp":1778704943,"startTime":"0","endTime":"0","summary":"Longeveron (NASDAQ:LGVN) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.16) by 18.75 percent. This is a 44.12 percent increase over losses of $(0.34) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52545344/longeveron-q1-eps-0-19-misses-0-16-estimate-sales-398-000k-beat-314-667k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Longeveron Q1 EPS $(0.19) Misses $(0.16) Estimate, Sales $398.000K Beat $314.667K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635753739","title":"Longeveron Q1 revenue rises, beats analyst estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635753739","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635753739?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:24","pubTimestamp":1778703879,"startTime":"0","endTime":"0","summary":"Longeveron Q1 revenue rises, beats analyst estimatesOverviewUS biotech firm's Q1 revenue rose and beat analyst expectationsNet loss for Q1 narrowed from prior yearCompany closed $30 mln private placem","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nL1N41Q166:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635758296","title":"BRIEF-Longeveron Q1 EPS USD -0.19","url":"https://stock-news.laohu8.com/highlight/detail?id=2635758296","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635758296?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:05","pubTimestamp":1778702746,"startTime":"0","endTime":"0","summary":"BRIEF-Longeveron Q1 EPS USD -0.19\n\n\nMay 13 (Reuters) - Longeveron Q1 revenue USD 378 thousand.\n\nQ1 gross profit USD 264 thousand\nQ1 operating expenses USD 5.039 million\nQ1 income from operations USD -4.775 million\nQ1 net income USD -4.736 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nPLXEDCA43:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635581997","title":"Longeveron Q1 Revenue USD 378 Thousand","url":"https://stock-news.laohu8.com/highlight/detail?id=2635581997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635581997?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:05","pubTimestamp":1778702701,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nPLXEDCA43:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635758067","title":"Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2635758067","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635758067?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:05","pubTimestamp":1778702700,"startTime":"0","endTime":"0","summary":"Stephen Willard, Chief Executive Officer, Longeveron Inc. (LGVN)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/13/3294435/0/en/Longeveron-Announces-2026-First-Quarter-Financial-Results-and-Provides-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","BK4575","BK4150","IND","AD","BK4139","LGVN","MSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635675828","title":"Longeveron Q1 net loss narrows 6% to $4.74 million; revenue rises to $398,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2635675828","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635675828?lang=en_us&edition=fundamental","pubTime":"2026-05-14 04:04","pubTimestamp":1778702681,"startTime":"0","endTime":"0","summary":"Longeveron posted a net loss of $4.74 million for the quarter ended March 31, 2026, narrowing 6% from a year earlier.Revenue in the quarter rose 4.46% to $398,000, while cost of revenues increased to $134,000.Operating loss improved to $4.78 million, as total operating expenses fell 7.64% to $5.04 million.Cash and cash equivalents totaled $15.8 million at March 31, 2026, with the company expecting that balance to fund operations into the fourth quarter of 2026.ELPIS II Phase 2b trial in hypoplastic left heart syndrome remains fully enrolled, with top-line results anticipated in August 2026 following an FDA Type C meeting that said right-ventricle ejection fraction is not an appropriate efficacy endpoint.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL4dYj9g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634237211","title":"Longeveron reports DMC approval for laromestrocel study to continue as designed","url":"https://stock-news.laohu8.com/highlight/detail?id=2634237211","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634237211?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:09","pubTimestamp":1778530181,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced that the independent data monitoring committee, or DMC, has completed its final prespecified data review for the ongoin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-reports-dmc-approval-for-laromestrocel-study-to-continue-as-designed-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-reports-dmc-approval-for-laromestrocel-study-to-continue-as-designed-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634340442","title":"Longeveron Cut to Hold From Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2634340442","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634340442?lang=en_us&edition=fundamental","pubTime":"2026-05-12 03:51","pubTimestamp":1778529060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LGVN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 11, 2026 15:51 ET (19:51 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634823530","title":"Longeveron downgraded to Hold from Buy at Maxim","url":"https://stock-news.laohu8.com/highlight/detail?id=2634823530","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634823530?lang=en_us&edition=fundamental","pubTime":"2026-05-11 23:43","pubTimestamp":1778514209,"startTime":"0","endTime":"0","summary":"Maxim downgraded Longeveron (LGVN) to Hold from Buy. Published first on TheFly – the ultimate source for real-time, market-moving breaking financia...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-downgraded-to-hold-from-buy-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-downgraded-to-hold-from-buy-at-maxim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634128445","title":"Longeveron DMC clears Phase 2b HLHS stem cell trial to complete","url":"https://stock-news.laohu8.com/highlight/detail?id=2634128445","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634128445?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:11","pubTimestamp":1778505068,"startTime":"0","endTime":"0","summary":"Longeveron disclosed an independent Data Monitoring Committee review that found no new safety concerns in its fully enrolled Phase 2b ELPIS II trial of laromestrocel in hypoplastic left heart syndrome, supporting completion of the study as planned.Results have not yet been presented; top-line data are expected in August 2026.Review outcome reduces near-term clinical hold risk, keeping a key rare-disease program on track ahead of a pivotal readout.Trial enrolled 40 pediatric patients across 12 US cardiac centers, with NIH-backed funding support cited for the study.Laromestrocel holds FDA Orphan Drug, Fast Track, and Rare Pediatric Disease designations for hypoplastic left heart syndrome, which could support an accelerated regulatory path if efficacy data are positive.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL4d2DrJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","SG9999014013.SGD","IE00B3QW5Z07.USD","SG9999014039.USD","IE00B64PRP62.GBP","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","SG9999014005.SGD","LU2095319765.USD","NDAQ","IE00BKPKM429.USD","LGVN","SG9999014021.USD","LU2210150020.SGD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BN0W2V16.EUR","BK4588","IE00BN0W2W23.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634284924","title":"Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2B Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (Hlhs)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634284924","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634284924?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:10","pubTimestamp":1778505000,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA5XCLZD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634284120","title":"Longeveron Inc - Top-Line Results From Elpis Ii Trial Anticipated in August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634284120","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634284120?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:10","pubTimestamp":1778505000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA5XCLZD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634228412","title":"Longeveron Inc - DMC Finds No Safety Concerns, Recommends Phase 2B Trial Continue to Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2634228412","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634228412?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:10","pubTimestamp":1778505000,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA5XCLZD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634984384","title":"Longeveron provides update on laromestrocel development after Type C meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2634984384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634984384?lang=en_us&edition=fundamental","pubTime":"2026-05-09 06:59","pubTimestamp":1778281158,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced that a constructive Type C meeting with the FDA was held in late March, with the FDA providing their meeting summary in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-provides-update-on-laromestrocel-development-after-type-c-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-provides-update-on-laromestrocel-development-after-type-c-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","LGVN","BK4585","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634460352","title":"Longeveron Updates FDA Path for ELPIS II Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2634460352","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634460352?lang=en_us&edition=fundamental","pubTime":"2026-05-09 05:24","pubTimestamp":1778275499,"startTime":"0","endTime":"0","summary":"An update from Longeveron ( ($LGVN) ) is now available. On May 8, 2026, Longeveron reported that a Type C meeting held with the U.S. Food and Drug ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-updates-fda-path-for-elpis-ii-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-updates-fda-path-for-elpis-ii-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LABU","BK4585","BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634462251","title":"Longeveron Says the FDA No Longer Sees Trial for Heart Syndrome Treatment as Pivotal","url":"https://stock-news.laohu8.com/highlight/detail?id=2634462251","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634462251?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:42","pubTimestamp":1778272920,"startTime":"0","endTime":"0","summary":"Longeveron said the Food and Drug Administration no longer refers to its Phase 2b clinical trial for a potential treatment for hypoplastic left heart syndrome  as pivotal.The biotechnology company said Friday the two parties did not land on an appropriate primary endpoint for the study in their Type C meeting in March. The FDA indicated the study's primary endpoint of right ventricle ejection fraction is not an appropriate endpoint to demonstrate efficacy, and indicated that the two parties would not be able to agree on a new primary endpoint while the trial remains ongoing given an interim analysis mandated and conducted by the National Institute of Health.However, Longeveron said the FDA indicated it is willing to meet again when the study is complete to discuss the results and align on a potential path forward. During the Type C meeting, the FDA acknowledged that HLHS is a rare disease associated with significant morbidity and mortality with a high unmet medical need for safe and ef","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","LABU","BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634640674","title":"Longeveron targets August ELPIS II Phase 2b HLHS data readout for laromestrocel","url":"https://stock-news.laohu8.com/highlight/detail?id=2634640674","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634640674?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:21","pubTimestamp":1778271670,"startTime":"0","endTime":"0","summary":"Longeveron disclosed a Type C meeting with FDA that reset regulatory expectations for laromestrocel in its ongoing Phase 2b ELPIS II study in hypoplastic left heart syndrome.FDA rejected right ventricle ejection fraction as suitable primary endpoint to support efficacy, leaving trial without an agreed endpoint that could underpin a pivotal program while study remains ongoing.Agency no longer characterizes ELPIS II as pivotal, raising execution risk for near-term BLA strategy despite continued openness to reassess path forward once study completes.Top-line ELPIS II results have not been presented yet; readout remains expected in August 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Longeveron Inc. published the original content us","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL2wGHW3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634464575","title":"Longeveron Inc - FDA Says New Primary Endpoint for Elpis Ii Cannot Be Agreed While Trial Ongoing","url":"https://stock-news.laohu8.com/highlight/detail?id=2634464575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634464575?lang=en_us&edition=fundamental","pubTime":"2026-05-09 04:05","pubTimestamp":1778270700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUA461KHS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":75,"code":"91000000","status":"200"}]}}